Trimi vs Eden: Weight Loss Telehealth

Trimi and Eden both provide telehealth weight loss programs with GLP-1 medications. While they share the goal of making weight loss treatment accessible, their pricing models, medication selections, and program philosophies differ. This guide helps you understand which platform is the better fit for your weight loss goals.

Quick Comparison

Platform Overview

Trimi

Trimi is a specialized GLP-1 weight loss program offering compounded semaglutide at $125/month, compounded tirzepatide at $125/month, and retatrutide. The monthly fee covers provider consultations, medication, and shipping. All medications are sourced from FDA-registered 503B compounding pharmacies. Trimi's clinical team focuses exclusively on GLP-1 therapy, bringing specialized expertise in dosing, side effect management, and long-term treatment optimization.

Eden

Eden offers a telehealth weight loss program with access to compounded GLP-1 medications. Their platform provides consultations with healthcare providers who evaluate patients for GLP-1 treatment and manage ongoing care. Eden has built a user-friendly platform and focused on patient experience throughout the treatment journey.

Where Eden excels: Eden has created a clean, accessible telehealth experience and has focused on making the onboarding process smooth for new patients. Their patient communication and support channels are well-organized, and they have invested in creating a positive patient experience from initial consultation through ongoing treatment.

Pricing Comparison

Trimi offers flat-rate pricing that does not change with dose adjustments. This predictability is important because most patients titrate to higher doses over time. When evaluating Eden's pricing, calculate the total monthly cost at your expected maintenance dose to make an accurate comparison. Consider whether pricing is dose-dependent, as this significantly affects long-term costs.

A 12-month comparison at Trimi's rates: semaglutide at $99/month totals $1,188 per year. Tirzepatide at $125/month totals $1,500 per year. Compare these figures against Eden's pricing at your expected maintenance dose for a true cost comparison.

Medication Options

Trimi offers three GLP-1 medications: semaglutide, tirzepatide, and retatrutide. This breadth gives providers more flexibility to match patients with the optimal medication and provides a fallback if the first medication does not produce desired results or causes intolerable side effects. Having retatrutide as a third option is particularly valuable, as the triple agonist has shown exceptional results in clinical trials.

Eden typically offers compounded semaglutide and tirzepatide. Confirm their current medication availability directly on their website, as offerings can change.

Clinical Approach

Both platforms connect patients with licensed healthcare providers. Trimi's model emphasizes GLP-1 specialization, with providers who focus exclusively on weight loss medication management. This specialization translates to deeper expertise in titration schedules, side effect mitigation, and the decision of when to switch medications for better results.

When evaluating either platform, ask about follow-up frequency, provider accessibility for questions between visits, and how dose adjustments are handled. These factors significantly influence treatment outcomes.

Who Each Program Is Best For

Choose Trimi If:

• You want flat-rate pricing at $99/month (semaglutide) or $125/month (tirzepatide)
• Access to three GLP-1 medications including retatrutide is important
• You want dedicated GLP-1 specialist providers
• Predictable costs without dose-dependent pricing increases matter to you

Choose Eden If:

• You are already enrolled in Eden's program and happy with your results
• Their platform design and patient experience appeal to you
• Their current pricing is competitive for your specific needs
• You value the specific features or support tools they offer

What We Admire About Eden

Eden has contributed to making GLP-1 weight loss treatment more accessible through telehealth. Their focus on patient experience and platform design demonstrates a genuine commitment to making healthcare feel approachable and manageable. More quality providers in this space ultimately benefits all patients by driving innovation and competitive pricing.

Getting Started

Compare total costs, medication options, and clinical support before choosing a platform. To learn more about Trimi, visit our treatment options page. Compounded semaglutide starts at $99/month and tirzepatide at $125/month, with no dose-dependent price increases.

Frequently Asked Questions

Is Trimi cheaper than Eden for GLP-1?

Trimi's flat-rate pricing of $99/month for semaglutide and $125/month for tirzepatide is designed to be highly competitive. Compare total monthly costs at your expected maintenance dose with Eden's pricing to determine which is more affordable for your specific treatment plan.

Does Eden offer retatrutide?

As of early 2026, Eden primarily offers compounded semaglutide and tirzepatide. Trimi additionally offers retatrutide for patients who may benefit from the triple agonist approach targeting GLP-1, GIP, and glucagon receptors simultaneously.

Can I switch from Eden to Trimi?

Yes. Switching between telehealth GLP-1 programs is straightforward. A Trimi provider will review your treatment history, current dose, and response before continuing or adjusting your plan.

Do both platforms include medication in their pricing?

Both Trimi and Eden include medication in their program pricing, though the specific structure may differ. Trimi's pricing is flat-rate regardless of dose. Confirm whether Eden's pricing varies by dose tier, as this affects long-term costs.